Skip to content

DOCTEUR LAISSUS

Active
Private limited companyfounded 2025active for 1 yearFond de Noulé 6, 4860 Pepinster, BelgiumKBO/BCE: BE 1028.449.032
Summary

DOCTEUR LAISSUS has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €5,833 and a net result of €2,833. Its solvency ranks better than 32% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €28,000turnover 2025, estimated
Equity
€5,833
Profit
€2,833
Turnover estimated from the gross margin
Financial health
92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 3 days early
Why 92lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.74, cash €5,664Figures for financial year 2025 (filed 28-07-2026)Size: total assets €14,704Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 39% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency 65
equity 39.7% of total assets
Liquidity 68
short-term debt 57.5% · cash 38.5%
Profitability 86
return on assets 19.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,153 companies, NACE 86, micro)
Credit of up to €500 on 30-day terms is acceptable
Liquidity ample (current ratio 1.74, above the usual 1.5; short-term debt: 57.5% and cash: 38.5% of total assets), but 60.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 33% on solvency, 49% on liquidity and 37% on profitability.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.74, cash €5,664
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 28-07-2026)
NBB · annual accounts
lowers risk · Size: total assets €14,704
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
3 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: LAISSUS Thomas Guy Francis…

Key points

  • Caution: Among the weakest 10% on equitysector median €124,506 · 20,661 companies €5,833 View
  • Founded 12 months agofounded 01-10-2025 12 months View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€14,704
Profit
€2,833
Solvency
39.7%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
01-10-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
63
Who signs
Each director alone
Annual meeting
30 June
Purpose
“L'exercice de l’art de guérir dans le domaine médical et plus précisément, la spécialité…” (deed in French)
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about DOCTEUR LAISSUS

What is the company number of DOCTEUR LAISSUS?
1028.449.032. In Belgium the VAT number is the company number with BE in front: BE 1028.449.032.
Where is DOCTEUR LAISSUS based?
The registered office is at Fond de Noulé 6, 4860 Pepinster.Company details
What does DOCTEUR LAISSUS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DOCTEUR LAISSUS?
Private limited company (BV).
When was DOCTEUR LAISSUS founded?
On 01-10-2025.
Is DOCTEUR LAISSUS still active?
Yes, DOCTEUR LAISSUS is an active enterprise in the KBO register.
What is the turnover of DOCTEUR LAISSUS?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DOCTEUR LAISSUS profitable?
In financial year 2025, DOCTEUR LAISSUS made a profit of €2,833.
Where can I find the annual accounts of DOCTEUR LAISSUS?
DOCTEUR LAISSUS filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to DOCTEUR LAISSUS

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.